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FOOD FOR THOUGHT
Nutritional basis of type 2 diabetes remission
Roy Taylor and colleagues explain how type 2 diabetes can be reversed by weight loss and 
avoidance of weight regain
Type 2 diabetes mellitus was once thought to be irreversible and progressive, but a series of clini-cal studies over the past 12 years have clarified the mechanisms 
that cause the disease. We now know that 
the processes that cause type 2 diabetes 
can be returned to normal functioning by 
restriction of food energy to achieve weight 
loss of around 15 kg.1 Around half of people 
who are within the first 10 years of diag-
nosis and manage to follow food energy 
restriction can stop all diabetes medication 
and return to non-diabetic glucose control.2 
3 Remission is achieved when haemoglo-
bin A1c concentrations of 48 mmol/mol 
are recorded after weight loss and at least 
six months later without any anti-diabetic 
medications (box 1).4 Here we summarise 
the new understanding of type 2 diabetes 
and consider how different changes to food 
intake can achieve the necessary weight 
loss and maintenance required for remis-
sion of diabetes.
What causes type 2 diabetes and remission?
In 2008 the twin cycle hypothesis postu-
lated that there were vicious cycles of fat 
accumulation in the liver and pancreas 
that lead to the development of type 2 dia-
betes over at least a decade (fig 1).6 The 
hypothesis was developed from emerging 
knowledge on the relation between liver fat 
and control of the constant flow of glucose 
into the blood as well as observation that 
normal insulin secretion returned after 
substantial weight loss in people with type 
2 diabetes. It predicted that major calorie 
restriction would lead to a rapid fall in liver 
fat, normalisation of liver insulin sensitiv-
ity, and decrease to normal levels of glucose 
production by the liver.
Testing the hypothesis required a sure-
fire way of achieving around 15 kg weight 
loss, and one of the most striking findings 
of the 2011 Counterpoint study was the 
acceptability of a low calorie liquid diet 
for a short planned period.1 People with 
type 2 diabetes in the study achieved an 
average of over 15 kg weight loss in eight 
weeks during normal living.1 Participants’ 
initially high levels of liver and pancreas 
fat fell to normal ranges, with decreased 
hepatic glucose output and improved β cell 
function. The study included only people 
who had had diabetes diagnosed within 
four years, but a subsequent study found 
that remission was much less likely after 10 
years of diabetes.2
These studies set the scene for Direct 
(Diabetes Remission Clinical Trial), a 
randomised controlled trial in primary 
care of a low calorie diet with structured 
follow-up compared with conventional 
management according to best practice 
guidelines.  This  study confirmed 
widespread acceptability, with almost 30% 
of those invited accepting to participate 
and an average weight loss of 14.5 kg.7 
Primary care nurses or dietitians worked 
with patients in the intervention group, 
and 36% (53/149) achieved remission for 
two years.8
Direct also showed that people in 
remission could return to normal maximal 
insulin secretion rates if they maintained 
their weight after initial rapid weight loss.9 
This complete return to normal functional 
β cell mass is remarkable. Previously, 
both clinical and histological studies on 
the pancreas found that β cell capacity 
declined to around 50% by the time of 
diagnosis, and death or apoptosis of the 
β cells had been assumed. But we now 
know that excess fat exposure causes β 
cells to de-differentiate, losing ability to 
secrete insulin10—most likely through 
downregulation of the genes controlling 
insulin production. The return to normal for 
a large group of people who used to have 
type 2 diabetes shows the potential for β 
cell recovery. Some individuals remain in 
remission for many years provided weight 
is not regained.11
Type 2 diabetes is characterised by 
accumulation of more fat in the liver 
and pancreas than an individual can 
tolerate. Different people have different 
fat thresholds, and this explains why only 
around half of people diagnosed with 
type 2 diabetes are obese and some have a 
healthy body mass index.12 13 The excess fat 
within liver cells causes insulin resistance, 
and this entirely resolves if liver fat falls to 
low-normal levels.12 14 Once this happens 
insulin can act normally again, restraining 
the outpouring of glucose from the liver into 
the blood and rapidly normalising fasting 
blood glucose concentrations.
Because the liver supplies triglyceride 
to the rest of the body, the sudden fall in 
liver fat causes the high rate of triglyceride 
supply to fall to normal.14 As a result, 
fat levels inside the pancreas gradually 
decrease, along with all ectopic fat depots. 
Gradually, normal insulin response to 
eating is restored.12 14 15
Any sustained decrease in calorie intake 
is able to remove the excess intra-organ fat. 
For example, the enforced sudden decrease 
KEY MESSAGES
•   Type 2 diabetes develops when per-
sonal tolerance for fat levels in the 
liver and pancreas are exceeded
•   Weight loss sufficient to reverse this 
will permit return to non-diabetic 
blood glucose in the early years after 
diagnosis
•   Remission is durable provided weight 
regain is avoided
•   Avoidance of weight regain can be 
achieved by various strategies and 
individuals must find the dietary strat-
egies most suited to them alongside 
increased physical activity 
•   To enable healthful dietary intakes 
in populations, policy interventions 
such as taxation on calorie dense 
foods and restrictions on portion size 
are needed.
Box 1: Definition of remission*
The consensus guideline from UK Primary 
Care Diabetes Society and Association of 
British Clinical Diabetologists lays out three 
criteria for remission of type 2 diabetes4:
• Weight loss
• Fasting plasma glucose <7 mmol/L or 
HbA1c <48 mmol/mol (WHO diagnostic 
thresholds) on two occasions separated 
by at least six months
• Attainment of these glycaemic 
parameters after complete cessation of 
all glucose lowering therapies
*Remission is sometimes used to describe meeting 
glycaemic targets even though hypoglycaemic drugs 
have not been stopped. Care must be taken in the 
interpretation of stated rates of remission.
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in food intake after bariatric surgery brings 
about remission by the same underlying 
mechanisms as voluntary dieting.15 16 
Bariatric surgery necessitates nil by mouth 
for a period followed by much reduced food 
intake and achieves around 64% remission 
of diabetes at two years.17
In the UK Prospective Diabetes Study, 
normalisation of fasting glucose levels was 
reported in 15% of participants following 
an initial dietary weight loss phase.18 The 
Look-Ahead randomised trial compared 
intensive physical activity advice plus 
dietary restriction with conventional 
management of type 2 diabetes.11 Although 
diabetes remission was not an outcome 
measure, the modest weight loss achieved 
led to remission in 11.5% of participants in 
the intensive lifestyle intervention group. 
Merely providing the information on the 
degree of weight loss required for remission 
can allow motivated people to achieve 
this for themselves using their preferred 
method.19
Key components of dietary advice
Low carbohydrate versus low calorie diets
Much noise and confusion surround the 
“best” macronutrient composition in die-
tary advice for weight loss. Low fat diets 
used to be favoured. This was because fat 
contains a higher density of calories (9 
kcal/g) than carbohydrate and protein (4 
kcal/g), coupled with concerns about the 
cardiovascular risks of higher fat diets. On 
the other hand, interest is increasing in low 
or very low carbohydrate diets for weight 
loss because carbohydrate is the primary 
contributor to post-prandial glycaemia. 
Table 1 summarises the main evidence 
comparing low calorie and low carbohy-
drate diets.
Randomised trials in general populations 
(not specific for diabetes) show that both 
low calorie and low carbohydrate diets 
can be effective for weight loss as long 
as participants can adhere to the diet.33 
Studies show slightly greater weight loss 
up to one year with low carbohydrate 
diets than low fat diets, with a modest 
difference of around 1 kg body weight,34 35 
but the scanty randomised trial evidence 
at two years shows no difference between 
diets.20 36
A non-randomised study with intensive 
follow-up reported that a very low 
carbohydrate approach in people with type 
2 diabetes can achieve and sustain weight 
loss of 12 kg at two years.28 Moreover, a two 
year follow-up of a cohort (not selected for 
diabetes) in a single British general practice 
reported a decrease in median weight of 8.3 
kg at two years on a low carbohydrate diet 
(50-130 g/day).30 For glycaemic control, a 
non-randomised study of a diet with less 
than 30 g/day of carbohydrate reported 
58% of participants achieving HbA1c 
<48 mmol/mol, but metformin was not 
discontinued.37 However, non-randomised 
or uncontrolled studies report data on 
completers and are therefore not directly 
comparable with randomised trials, which 
analyse by intention to treat and outcomes. 
Randomised trials are generally considered 
to provide the highest quality of evidence 
when they are feasible.
To our knowledge only one randomised 
trial has reported diabetes remission rates 
after a low carbohydrate diet intervention 
in patients with poorly controlled 
glycaemia. However, as metformin was 
continued the participants did not meet 
the current definition of remission (box 1). 
Participants in the intervention group lost 
3.7 kg more than those in the comparator 
group and 11% (12/109) achieved HbA1c 
<48 mmol/mol compared with 0/117 in the 
comparator group.31
Heterogeneity in definitions also makes 
interpretation difficult. What constitutes 
a low carbohydrate diet varies widely 
across studies from <45% of total energy22 
to ketogenic levels of intake of under 50 
g/day (<10% of energy).28Box 2 gives a 
standardised definition.
Dietary restriction through eating strategies
Portion control is an established strategy 
for weight loss, as is the concept of fasting: 
short term dietary self-restraint was tradi-
tionally associated with religious practices. 
Intermittent fasting has become popular 
more recently. Daily or alternate day fast-
ing aims for roughly 25% lower intake of 
food energy: the 5:2 diet reduces intake 
to 500 to 700 calories a day for two days 
each week, while time restricted feeding 
limits eating to within a 6 to 8 hour win-
dow each day (for instance, omit break-
fast and eat only between 12 pm and 6 
pm). Systematic reviews show that each 
of these eating strategies can be effective, 
with reports of weight loss of up to 13% of 
baseline weight,39 and that different inter-
mitting fasting approaches achieve similar 
weight losses as the traditional continu-
ous energy restriction approach.40 41 How-
ever, the existing randomised trials are of 
short duration with small sample size and 
heterogeneity across studies, and further 
research is warranted to test whether these 
approaches can be effective for the remis-
sion of type 2 diabetes.39 42 Beyond weight 
loss, intermittent fasting may have longer 
term effects on health and longevity.43 Chal-
lenges such as hunger and cravings on fast-
ing days could be too great for some despite 
evidence that these diminish over time.43
Dietary quality
Food is eaten within overall sociocul-




















Fig 1 | Type 2 diabetes develops as long term intake of excess food energy leads to 
accumulation of liver fat, driven by a vicious cycle of hepatic insulin resistance and 
hyperinsulinaemia. The raised liver fat level causes increased hepatic export of very low 
density lipoprotein (VLDL) triglycerides. If the subcutaneous fat depot cannot accommodate 
this, ectopic fat will build up, including in the pancreas. In people with susceptible β cells, the 
acute insulin response to food becomes diminished and de novo lipogenesis from glucose is 
enhanced. β Cell function can be restored if liver fat is reduced through weight loss. Figure is 
modified from Al-Mrabeh et al with permission5
FOOD FOR THOUGHT
the bmj | BMJ 2021;373:n1449 | doi: 10.1136/bmj.n1449 3
quantity or type of macronutrients may 
be over simplistic. Different food sources 
affect physiological pathways differently, 
including appetite, satiety, hunger, and diet 
induced thermogenesis. Reducing all car-
bohydrates indiscriminately may take away 
the benefits from the consumption of fibre 
and wholegrain. Decades of research have 
clarified the importance of distinguishing 
between saturated, unsaturated, and trans 
fats for cardiometabolic disease.44-46 Fur-
thermore, even considering saturated fats 
as a group is not sufficiently discriminatory 
to understand health effects because indi-
vidual saturated fatty acids differ in their 
association with type 2 diabetes.47
The importance of food sources rather 
than macronutrient type is highlighted by 
the associations of meat and dairy, which 
are both typically high in saturated fat and 
protein, with cardiometabolic risk. Some 
types of dairy such as fermented dairy 
(yoghurt or cheese) are associated inversely 
with type 2 diabetes and cardiovascular 
disease, whereas red and processed meat 
are positively associated.45 48 49
Advice on foods consumed within an 
overall dietary pattern may facilitate better 
longer term adherence. Evidence supports 
the benefits of Mediterranean-type diets 
for several health outcomes, although this 
dietary pattern is not singularly superior or 
easier to adhere to. Other effective dietary 
patterns include DASH (dietary approaches 
to stop hypertension), the healthy eating 
index, Nordic diet, and vegetarian or 
other meal plans, but more research is 
needed.50 Consensus is also emerging that 
avoidance of ultraprocessed foods and 
increased consumption of fresh, whole 
foods has health benefits, including for 
weight and glycaemic control. Food based 
dietary guidelines that move beyond a 
focus on macronutrients and consider 
overall dietary and social contexts would 
communicate our current knowledge on 
nutrition and its effect on type 2 diabetes 
more comprehensively.
Remission in ethnically diverse and global 
populations
Most participants in studies on remission 
of type 2 diabetes carried out in western 
countries have been white, and background 
nutritional patterns of other ethnicities 
have to be considered.7 51 The Look-Ahead 
study included around 38% ethnic minor-
ity participants (mainly Hispanic and Afri-
can American). Although not a primary aim 
of the study, remission of type 2 diabetes 
was observed in proportion to weight loss 
(11.5% (248/2157) at year 1 and 7.3% 
(150/2056) at year 4, with weight loss of 
8.6% and 4.7%, respectively); no asso-
ciation of ethnicity with remission was 
observed.11 A large community based anal-
ysis from the Kaiser Permanente Northern 
California Registry showed a higher likeli-
hood of remission in African Americans 
than in the white population, with overall 
Table 1 | The controversy about low carbohydrate or low calorie approaches to remission of type 2 diabetes: Areas of agreement and disagreement
  Low or very low carbohydrate diets Low or very low calorie diets†
Good for cardiovascular health Improves indices of cardio-vascular risk for up to 2 years20 21 Improves QRISK score up to 2 years8
Long term outcome data Not available Not available
Long term weight management The major problem. Need for continuing support and rescue 
management of weight regain
The major issue. Need for continuing support and rescue 
 management of weight regain
Acceptability Single centre reports acceptability22 RCT data to 2 years shows ongoing compliance in the majority.8 
Psychological study reports good acceptability up to 6 months23
Weight loss:
 RCT evidence Significant difference from controls at 6 months only (reduction 
in the low carb group of 2.6-11.1 kg at 6 months, 3.1-9.8 kg at 1 
year, and 2.0-6.8 kg at 2 years20 21 24
Significantly different from controls up to 2 years.8 25 26 Weight loss 
around 10 kg in the active arm at 12 months in Direct and Droplet 
and 7.6 kg at 2 year in Direct26 27
 Observational studies Selected paying participants achieved 10 kg weight loss at 2 
years.‡28 
A 1 year study reported 4.3 kg weight loss in a 1% sample 
 completing follow-up (1000/105 950 initially signed up)29
Mean weight loss of 13.7 kg at 6 months2
Improvement in glucose control:
 RCT evidence Meta-analyses of multiple trials show significant decrease in 
HbA1c of 0.3-1.5% at 6 months. Decreases of 0.3-1.0% at 1 year 
and 0-0.6% at 2 years were not significantly different from active 
controls20 21
One multisite trial found clinically important decrease in HbA1c at 
6, 12, and 24 months with 36% remission at 2 years8
 Observational studies Private clinic participants undertaking a very low carb diet while 
continuing hypoglycaemic agents achieved 0.9% decrease in 
HbA1c28 
A 1 year study reported 0.3% decrease in HbA1c in 1000 people29
Observational data with withdrawal of all hypoglycaemic agents 
achieved a 1.1% fall in short duration diabetes and 0.6% fall in 
long duration diabetes over 6 months.2
Remission of type 2 diabetes A primary care series reports 46% of completers on continued 
metformin were in remission at an average of 2 years30 
Non-randomised cohort reports 17.6% at 2 years28 
RCT evidence of remission following weight management based 
on low carbohydrate diet in 11% at 1 year‡¶31
RCT evidence of remission in 46% by intention to treat off all 
diabetes drugs at 12 months and 36% at 24 months from 
Direct.8 Diadem-1 in a Middle Eastern population achieved 61% 
remission. Observational studies of remission confirm these 
effects.12 32§
*Low: 50-130 g/day or between 10-26% total energy; Very low: 20-50 g/day or under 10% total energy
†700-1000 kcal/day (or 35-50% of a 2000 kcal/day intake) for a defined period then weight maintaining diet
‡This study used <30 g/day of carbohydrate initially.
¶Oral hypoglycaemic agents not stopped on commencing the diet.
§All oral hypoglycaemic agents were stopped on commencing the diet in all studies.
Box 2: What is a low carbohydrate diet?
The term “low carbohydrate” is used 
in various ways. Recommendations for 
consistency of approach have been made, 
the most widely used being that of Feinman 
and colleagues38:
• Very low carbohydrate: 20 to 50 g/day 
(≤10% of energy, based on 2000 kcal/
day)
• Low carbohydrate: >50 to <130 (>10% to 
<26%)
• Moderate carbohydrate: 130 to 230 (26% 
to 45%)
• High carbohydrate >230 (>45%) 
Dietary adherence is always problematic, 
with substantial differences in prescribed 
and attained macronutrient intakes. The 
best diet for longer term success will be one 
which is easiest for an individual to adhere 
to in the long term.
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seven year remission of 4.6% among peo-
ple with type 2 diabetes for less than two 
years.52 A similar retrospective survey of 
people aged over 65 years observed higher 
rates of non-surgical remission after eight 
years in Asian and Hispanic people than in 
white and African American groups.53
South Asians achieve remission after a 
low calorie liquid diet similarly to white 
Europeans.54 A two year prospective study 
of a low calorie diet and advice to walk 
daily in a young South Asian population 
with recent onset type 2 diabetes found 
75% remission at three months and 69% 
at two years. HbA1c was <39 mmol/mol 
in 53% of participants at three months 
and in 47% at two years; 22% had HbA1c 
39-47 mmol/mol at both time points.55 
Similar observations were made in a Thai 
population: 79% had achieved remission 
at 12 weeks (with an average weight loss of 
10 kg) and 30% had maintained remission 
at 12 months.56 A trial in a Middle Eastern 
population observed remission in 61% of 
those allocated to total diet replacement 
and lifestyle intervention.25
A recent study in Barbados on a 
predominantly African Caribbean 
population observed rates of weight 
loss induced remission similar to those 
documented in Direct.32 This was achieved 
over eight weeks by using a hypocaloric 
liquid diet (760 kcal) with withdrawal of 
diabetes medication on day 1 of the diet. 
Nine of the 11 (82%) participants who 
lost at least 10 kg achieved non-diabetic 
fasting blood glucose levels compared 
with six of 14 (43%) who lost <10 kg. 
Remission of prediabetes by weight loss 
and physical activity has also been shown 
in Indian populations, with significant 
improvements in insulin resistance and β 
cell function.57 58
Evidence on ways to improve long term 
remission
The US national registry has documented 
the feasibility of people maintaining sub-
stantial weight loss over 10 years and has 
provided important insights into nutri-
tional and other factors.59 Weight regain 
was fastest for participants in the early 
years of follow-up, with decreasing rates 
over each of the first five years followed 
by stable maintenance over the subse-
quent five years, suggesting that main-
tenance requires less effort over time. 
Many personal factors influence what we 
eat and therefore how well weight loss is 
maintained, including age, sex, genetics, 
ethnicity, body fat status, level of physical 
activity, and family and social culture. But 
there are also profound wider influences on 
food intake. These include food availability, 
accessibility, cost, advertising, ready avail-
ability of fast food takeaways and home 
delivery options, and price promotions for 
processed energy dense foods.
Psychological study of participants 
in weight loss studies of remission has 
shown support from family and friends 
has a critical role in both achieving weight 
loss and avoiding regain.23 60 Eating is a 
social activity, with individuals tending to 
eat similarly to their family and friendship 
groups. The psychological term “behaviour 
contagion” is descriptive, and it is notable 
that spouses or partners often report weight 
loss. Given that type 2 diabetes runs in 
families, all, including children, are likely 
to benefit.
Continued support from healthcare 
professionals, irrespective of composition of 
food advised, is one strategy to avoid weight 
regain and sustain diabetes remission. In 
Direct a “rescue plan” of partial or total meal 
replacement was offered to participants 
who regained 2 kg or 4 kg, respectively.8 
More research is needed, but observational 
evidence indicates that maintaining weight 
loss over 10 years requires sustained 
dietary change, regular physical activity, 
and frequent self-weighing.59 61
Population strategies, including 
education, dietary guidelines, and 
empowerment to make healthy food 
choices, such as clear food labelling, 
are necessary but not yet universally 
available. Evidence supports the case for 
other population “nudge” interventions, 
including taxation, restriction of fast food 
outlets near schools, and reducing the size 
and appeal of food portions, packages, 
and tableware to influence the quantities 
of food and beverages consumed.62 Another 
potentially clinically and economically 
effective strategy is food prescription to 
promote healthier eating. Pilot data from 
the US on people with uncontrolled type 
2 diabetes and food insecurity shows 
substantial reductions in HbA1c in those 
who received fresh food on prescription.63
Future directions
Type 2 diabetes can be reversed by substan-
tial weight loss in the early years after diag-
nosis, and the pathophysiological basis of 
this is now clear. Long term maintenance 
of weight loss brings about lasting remis-
sion, but this is more difficult to achieve 
than weight loss. Strategies to optimise the 
avoidance of weight regain in the long term 
need to be developed and rigorously tested 
in all populations. Population strategies 
are also required to enable healthier food 
choices and prevent the current excessive 
weight gain during childhood and adult 
life. Long term surveillance of people with 
type 2 diabetes in remission is needed to 
determine whether it also decreases the 
rates of vascular events and weight related 
cancers. 
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